InvestorsHub Logo
Followers 8
Posts 6947
Boards Moderated 0
Alias Born 07/31/2006

Re: None

Friday, 01/11/2013 11:41:36 AM

Friday, January 11, 2013 11:41:36 AM

Post# of 1282
July 2011 Press Release Too Funny For Words:

(1888PressRelease) July 05, 2011 - Los Angeles, CA - Ever since Genesis Biopharma Inc. producers of targeted cancer therapies, has announced that Mr. Anthony Cataldo shall be the Chairman and CEO of the company, there's been a positive vibe that he's sure to change the company's prospects with his vast experience. Tony has more than 20 years f experience in managing publicly traded companies in various sectors including VoIP and media.

A former employee of the US Air Force, he brings along the rigors needed to lead a publicly traded company. He is also the Chairman, CEO and Director of Oxis International Inc., ( that lasted until October 25,2011) a position he has held since 2009. He has also served as a non executive Co-Chairman of the Board of MultiCell Technologies, a company that supplies functional non tumorigenic immortalized human hepatocytes. As the Chairman of the company, he led the company from a debt worth millions of dollars to success? success?. From 2006 to 2008, he has served as Chairman and CEO of VoIP.( Company Now out of business stiffing payroll to its employees) He is also the CEO of the board of Green St. energy, a company that has forayed into the alternative energy business.(Another Cataldo dead in the water company) From August 1995 to 1998, Tony Cataldo served as the President and Chairman at Senetak, PLC a company that's involved in age related therapies.

"It's very important that the biotechnology industry uses its experience and resources to find cure to chronic diseases and to help them recover quickly. A classic example is Genesis's latest product that aims to cure Stage IV metastatic melanoma. Our Advisory board comprises of leading oncology researchers, and clinicians in the US. These personalized medicines are sure to help people suffering from chronic diseases. Research in biotechnology not only helps to save lives, but also manages to reduce health care costs and keep the country ahead when it comes to innovative therapeutics," says Tony Cataldo when asked about his contribution to the company.

As earlier said, Tony has vast experience over a wide variety of industries including media and VoIp.( All Failures selling at less than 2 cents a share, all but one under a penny) ) He has served as the CEO and Chairman of the Board of Directors of Miracle Entertainment, Inc. where he was the executive producer of several motion pictures.( Name one successful one.)

About Tony Cataldo: 58 year old Tony Cataldo ( actually in July 2011 Tony was 60 years old so this is just a blatant lie) is an inspiration to many in the biotechnology industry and has more than 2 decades of experience in handling publicly traded companies.( Maybe this will be his FIRST successful one. GNBP Stock in July 2011 was at about $ 1.40 a share. Its now less than 14 cents. so I guess not.)

Par for the course....

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.